PARVB promotes malignant melanoma progression and is enhanced by hypoxic conditions
Beta-Parvin (PARVB) is an actin-binding protein with functionality in extracellular matrix binding. Recent studies suggest its potential as a biomarker for various cancers, given its role in governing several malignancies. Yet, its involvement and modulatory mechanisms in malignant melanoma remain u...
| Published in: | Translational Oncology |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-04-01
|
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1936523323002474 |
